A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia
Clinical trial NCT01947803 · COMPLETED
Trial details
- NCT number
- NCT01947803
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-03-01
- Enrollment
- 353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.